Lumida
/RYZ
⌘K
RYZ

RYZ

RYZ
$29.60USD+0.65%+0.19 today

MARKET CAP

1.5B

P/E (TTM)

FWD P/E

33.3x

DAY RANGE

$29 – $30

52W RANGE

$19
$31

The case for & against

Bull & Bear analysis

Bullish

Company C is a notable player in the consumer goods sector, specializing in innovative health and wellness products. It has established a market position by leveraging its strong branding and product quality, targeting a demographic increasingly focused on health-conscious choices. The company operates within the rising trend of health awareness among consumers, positioning itself to capitalize on this enduring market theme.

Bull says

  • Earnings yield at 63.7% signals attractive valuation.
  • Positive revisions score indicates upward analyst earnings momentum.
  • Strong QS score reflects solid operational performance and growth.
  • Interest sensitivity low at 0.44 boosts financing capacity.
  • Health trend drives demand; new wellness product launches ahead.
  • Efficiency initiatives could improve margins over coming quarters.

Bear says

  • Profitability score deeply negative, signalling margin management issues.
  • High leverage increases refinancing risk if rates rise.
  • Elevated short interest reflects broad investor skepticism.
  • Negative dividend yield deters income-oriented investors.
  • Limited institutional ownership suggests weak large-investor support.
  • Competitive and regulatory pressures may further squeeze margins.

Investment themes with RYZ

Infrastructure Development -0.08%

AMRZ · ATI · RBC